EPISODE · Mar 12, 2026 · 8 MIN
Retatrutide: The Triple Agonist That Outperforms Every GLP-1 on the Market
from Unbreakable Vitality · host Daniel Rasmussen
Most weight loss interventions treat the symptom. Retatrutide addresses the system.In this episode of Unbreakable Vitality, we break down why Retatrutide, a first-in-class triple hormone receptor agonist, is becoming a cornerstone of precision metabolic medicine for high-performers with stubborn visceral fat, insulin resistance, and inflammatory markers that won't budge despite optimized lifestyle.This episode covers: why Retatrutide outperforms Semaglutide and Tirzepatide, how we prepare the metabolic terrain before prescribing it, and the full biomarker panel we use to protect lean mass, thyroid function, and hormonal balance throughout the protocol.This isn't a shortcut. It's a precision reset, designed for people ready to reclaim their metabolic baseline and build on it.🎟 Join the next Ageless Future Longevity Summit (Seattle)https://agelessfutureseattle.com/event/Join Our CommunityConnect with us to get the latest insights on longevity, precision medicine, and health optimization strategies to help you thrive. Follow us on social media for exclusive tips, updates, and cutting-edge therapies to extend your HealthSpan:🌟 Instagram: Follow @pinnaclehealth | @ageless.future.seattle for daily health tips and behind-the-scenes content.📘 Facebook: Like Pinnacle Integrative Health for updates on our latest episodes and events.🎥 YouTube: Subscribe to @IntegrativeMedicineSeattle for in-depth videos on Unbreakable Vitality and more.Get Started TodayTake our quick quiz at www.echelon-longevity.com/quiz to discover your personalized path to longevity. Don’t miss out, connect with us today and take control of your health journey!🌐 https://agelessfutureseattle.com/event/📩 Contact us to begin your journey!
Embed this episode
What this episode covers
Most weight loss interventions treat the symptom. Retatrutide addresses the system. In this episode of Unbreakable Vitality, we break down why Retatrutide, a first-in-class triple hormone receptor agonist, is becoming a cornerstone of precision metabolic medicine for high-performers with stubborn visceral fat, insulin resistance, and inflammatory markers that won't budge despite optimized lifestyle. This episode covers: why Retatrutide outperforms Semaglutide and Tirzepatide, how we prepare t...
NOW PLAYING
Retatrutide: The Triple Agonist That Outperforms Every GLP-1 on the Market
No transcript for this episode yet
Similar Episodes
No similar episodes found.
Similar Podcasts
No similar podcasts found.